Identifying a Level of Neutralizing Antibody That Correlates With Protection From Clinical Mumps Disease During a 2017 Mumps Outbreak Among Military Service Members
Open Access
- 17 June 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 11 (7) , ofae329
Abstract
Background: In 2017, a mumps outbreak occurred in a US military barracks. Serum collected at service entry was used to compare pre-exposure with presumptive vaccine-induced antibody levels from persons who developed mumps (cases) and potentially exposed persons who did not develop mumps (non-cases). Sufficient information to determine levels of exposure during the outbreak was not available. Methods: Pre-outbreak serum samples from the Department of Defense Serum Repository were available from 254 potentially exposed service members. Twelve developed clinical symptoms and had post-outbreak serum collected. All sera were tested with a mumps-specific enzyme immunoassay for immunoglobulin M, immunoglobulin G (IgG), and IgG avidity. The neutralizing antibodies to vaccine strain (Jeryl Lynn [JL], genotype A) and wildtype virus (genotype G) was assessed by a plaque reduction neutralization test. A Fisher exact test and receiver operator characteristic curve were used to analyze the antibody response for non-cases and mumps cases. Results: Eight mumps cases were laboratory confirmed. Pre-outbreak neutralizing antibody titers to JL and genotype G mumps virus and pre-outbreak IgG index values were proportionately lower for most cases as compared with exposed non-cases. When compared with potentially exposed non-cases, cases with clinical symptoms had greater odds of having a pre-outbreak JL titer <41 and a genotype G titer <16. Conclusions: We identified potential correlates of protection for mumps neutralizing antibody titers against JL and genotype G mumps viruses.Keywords
Funding Information
- Centers for Disease Control and Prevention (D-762-17)
This publication has 25 references indexed in Scilit:
- Disentangling the causes of mumps reemergence in the United StatesProceedings of the National Academy of Sciences, 2023
- Decreased humoral immunity to mumps in young adults immunized with MMR vaccine in childhoodProceedings of the National Academy of Sciences, 2019
- Mumps outbreak and MMR IgG surveillance as a predictor for immunity in military traineesVaccine, 2019
- Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak ControlNew England Journal of Medicine, 2017
- Mumps Outbreak in a Highly Vaccinated University-Affiliated Setting Before and After a Measles-Mumps-Rubella Vaccination Campaign—Iowa, July 2015–May 2016Clinical Infectious Diseases, 2017
- Mumps virus pathogenesis: Insights and knowledge gapsHuman Vaccines & Immunotherapeutics, 2016
- Antibody Induced by Immunization with the Jeryl Lynn Mumps Vaccine Strain Effectively Neutralizes a Heterologous Wild‐Type Mumps Virus Associated with a Large OutbreakThe Journal of Infectious Diseases, 2008
- Mumps Vaccine Performance among University Students during a Mumps OutbreakClinical Infectious Diseases, 2008
- Incidence of mumps and immunity to measles, mumps and rubella among US military recruits, 2000–2004Vaccine, 2008
- A mumps epidemic on St. George Island, AlaskaJAMA, 1967